---
layout: post
title: "Endpoints and Trial Designs To Advance Drug Development in Kidney Transplantation; Public Meeting"
date: 2026-02-05 18:56:45 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-19405
original_published: 2023-09-08 00:00:00 +0000
significance: 8.00
---

# Endpoints and Trial Designs To Advance Drug Development in Kidney Transplantation; Public Meeting

**Published:** February 05, 2026 18:56 UTC
**Source:** Federal Register
**Original Published:** September 08, 2023 00:00 UTC
**Document Number:** 2023-19405

## Summary

The Food and Drug Administration (FDA or we) is announcing the following public meeting on "Endpoints and Trial Designs To Advance Drug Development in Kidney Transplantation."

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/09/08/2023-19405/endpoints-and-trial-designs-to-advance-drug-development-in-kidney-transplantation-public-meeting)
- API: https://www.federalregister.gov/api/v1/documents/2023-19405

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
